
9 min
Sanofi's Pharma Reinvention: How Dupixent and mRNA Are Reshaping the Group
Inside Sanofi's radical transformation from diversified pharmaceutical conglomerate to focused immunology and mRNA powerhouse, with €50B+ in pipeline value.
Companies
Europe's largest drugmaker mid-reinvention around immunology.
3 published dossiers